Pink Sheet Podcast: Oncology Reviews, Biosimilars, and More Biosimilars
Executive Summary
Our discussion of US FDA's two-drug Oncologic Drugs Advisory Committee meeting, the recent biosimilar insulin public hearing, and the new final biosimilar interchangeability guidance.